Chronic Traumatic Encephalopathy : The Neuropathological Legacy of Traumatic Brain Injury

Obesity, a worldwide epidemic, confers increased risk for multiple serious conditions, including cancer, and is increasingly recognized as a growing cause of preventable cancer risk. Chronic inflammation, a well-known mediator of cancer, is a central characteristic of obesity, leading to many of its complications, and obesity-induced inflammation confers additional cancer risk beyond obesity itself. Multiple mechanisms facilitate this strong association between cancer and obesity. Adipose tissue is an important endocrine organ, secreting several hormones, including leptin and adiponectin, and chemokines that can regulate tumor behavior, inflammation, and the tumor microenvironment. Excessive adipose expansion during obesity causes adipose dysfunction and inflammation to increase systemic levels of proinflammatory factors. Cells from adipose tissue, such as cancer-associated adipocytes and adipose-derived stem cells, enter the cancer microenvironment to enhance protumoral effects. Dysregulated metabolism that stems from obesity, including insulin resistance, hyperglycemia, and dyslipidemia, can further impact tumor growth and development. This review describes how adipose tissue becomes inflamed in obesity, summarizes ways these mechanisms impact cancer development, and discusses their role in four adipose-associated cancers that demonstrate elevated incidence or mortality in obesity. 421 Click here to view this article's online features: • Download figures as PPT slides • Navigate linked references • Download citations • Explore related articles • Search keywords ANNUAL REVIEWS Further A nn u. R ev . P at ho l. M ec h. D is . 2 01 6. 11 :4 21 -4 49 . D ow nl oa de d fr om w w w .a nn ua lr ev ie w s. or g A cc es s pr ov id ed b y C or ne ll U ni ve rs ity W ei ll M ed ic al C ol le ge o n 09 /2 9/ 16 . F or p er so na l u se o nl y. PM11CH17-Hsueh ARI 10 May 2016 10:30

[1]  Qijun Wu,et al.  Circulating adiponectin, leptin and adiponectin–leptin ratio and endometrial cancer risk: Evidence from a meta‐analysis of epidemiologic studies , 2015, International journal of cancer.

[2]  C. Hutter,et al.  Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants , 2015 .

[3]  Graham A. Colditz,et al.  Prevalence of Overweight and Obesity in the United States, 2007-2012. , 2015, JAMA internal medicine.

[4]  S. Upala,et al.  Bariatric surgery and risk of postoperative endometrial cancer: a systematic review and meta-analysis. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[5]  M. Kew Obesity as a cause of hepatocellular carcinoma. , 2015, Annals of hepatology.

[6]  Alisha M. Mendonsa,et al.  Modulation of the Leptin Receptor Mediates Tumor Growth and Migration of Pancreatic Cancer Cells , 2015, PloS one.

[7]  Sean M. Kearney,et al.  Adipose-derived stems cells and their role in human cancer development, growth, progression, and metastasis: a systematic review. , 2015, Cancer Research.

[8]  G. Hu,et al.  New horizons in tumor microenvironment biology: challenges and opportunities , 2015, BMC Medicine.

[9]  O. Mandelboim,et al.  NK cells link obesity-induced adipose stress to inflammation and insulin resistance , 2015, Nature Immunology.

[10]  M. Rigla,et al.  Does bariatric surgery reduce cancer risk? A review of the literature. , 2015, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[11]  Qinghua Sun,et al.  Macrophage recruitment in obese adipose tissue , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[12]  J. Gimble,et al.  Concise Review: The Obesity Cancer Paradigm: Exploration of the Interactions and Crosstalk with Adipose Stem Cells , 2015, Stem cells.

[13]  W. Shi,et al.  The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue–resident regulatory T cells , 2015, Nature Immunology.

[14]  C. Hudis,et al.  Obesity and cancer: local and systemic mechanisms. , 2015, Annual review of medicine.

[15]  Shuming Sun,et al.  IL-25 Elicits Innate Lymphoid Cells and Multipotent Progenitor Type 2 Cells That Reduce Renal Ischemic/Reperfusion Injury. , 2015, Journal of the American Society of Nephrology : JASN.

[16]  C. Giordano,et al.  The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression , 2014, Front. Oncol..

[17]  P. Schumacker,et al.  Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? , 2014, Nature Reviews Cancer.

[18]  D. Gozal,et al.  Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. , 2014, Cell metabolism.

[19]  P. Scherer,et al.  Hyperglycemia as a Risk Factor for Cancer Progression , 2014, Diabetes & metabolism journal.

[20]  K. Bhaskaran,et al.  Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults , 2014, The Lancet.

[21]  A. Courcoulas,et al.  Bariatric surgery for obesity and metabolic conditions in adults , 2014, BMJ : British Medical Journal.

[22]  A. Brenner,et al.  NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions. , 2014, Cancer research.

[23]  D. Cipolletta Adipose tissue‐resident regulatory T cells: phenotypic specialization, functions and therapeutic potential , 2014, Immunology.

[24]  J. O’Sullivan,et al.  Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive , 2014, British Journal of Cancer.

[25]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[26]  J. Olefsky,et al.  Macrophages, immunity, and metabolic disease. , 2014, Immunity.

[27]  J. Lara,et al.  The Effects of Bariatric Surgery on Colorectal Cancer Risk: Systematic Review and Meta-analysis , 2014, Obesity Surgery.

[28]  M. Singer,et al.  Metabolic Health Reduces Risk of Obesity-Related Cancer in Framingham Study Adults , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[29]  X. Shu,et al.  Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women , 2014, Breast Cancer Research and Treatment.

[30]  Z. Yao,et al.  Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling , 2014, Oncotarget.

[31]  Z. Derdák,et al.  Obesity-associated mechanisms of hepatocarcinogenesis. , 2014, Metabolism: clinical and experimental.

[32]  K. Flegal,et al.  Prevalence of childhood and adult obesity in the United States, 2011-2012. , 2014, JAMA.

[33]  I. Fonseca,et al.  Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression , 2014, BMC Cancer.

[34]  Liang Song,et al.  Interleukin-6 in inflammatory and malignant diseases of the pancreas. , 2014, Seminars in immunology.

[35]  R. Gonzalez-Perez,et al.  Leptin–cytokine crosstalk in breast cancer , 2014, Molecular and Cellular Endocrinology.

[36]  J. Reynolds,et al.  The role of obesity in gastrointestinal cancer: evidence and opinion , 2014, Therapeutic advances in gastroenterology.

[37]  K. Clément,et al.  Insulin resistance and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach. , 2013, The American journal of clinical nutrition.

[38]  R. Locksley,et al.  Cutting Edge: IL-25 Elicits Innate Lymphoid Type 2 and Type II NKT Cells That Regulate Obesity in Mice , 2013, The Journal of Immunology.

[39]  Jeff S. Jasper,et al.  27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology , 2013, Science.

[40]  L. Girard,et al.  27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. , 2013, Cell reports.

[41]  A. Diehl,et al.  NAFLD, NASH and liver cancer , 2013, Nature Reviews Gastroenterology &Hepatology.

[42]  G. Mills,et al.  Favorable modulation of benign breast tissue and serum risk biomarkers is associated with >10 % weight loss in postmenopausal women , 2013, Breast Cancer Research and Treatment.

[43]  E. Lengyel,et al.  Adipose tissue and adipocytes support tumorigenesis and metastasis. , 2013, Biochimica et biophysica acta.

[44]  D. Silverman,et al.  Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort. , 2013, The American journal of clinical nutrition.

[45]  K. Ladell,et al.  Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3− T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells , 2013, Mucosal Immunology.

[46]  E. Rosen,et al.  Interferon Regulatory Factor 4 Regulates Obesity-Induced Inflammation Through Regulation of Adipose Tissue Macrophage Polarization , 2013, Diabetes.

[47]  Geoffrey S. Tobias,et al.  Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium , 2013, Cancer Causes & Control.

[48]  D. Mathis Immunological goings-on in visceral adipose tissue. , 2013, Cell metabolism.

[49]  Z. Tabka,et al.  Diet and diet combined with chronic aerobic exercise decreases body fat mass and alters plasma and adipose tissue inflammatory markers in obese women , 2015, Pediatric Rheumatology.

[50]  Yongmei Yin,et al.  Systematic Review and Meta-Analysis on the Association between IL-1B Polymorphisms and Cancer Risk , 2013, PloS one.

[51]  W. Frankel,et al.  Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner. , 2013, Cancer research.

[52]  J. Wojta,et al.  Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue , 2013, International Journal of Obesity.

[53]  P. Hojman,et al.  The role of intratumoral and systemic IL-6 in breast cancer , 2013, Breast Cancer Research and Treatment.

[54]  R. Locksley,et al.  Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages , 2013, The Journal of experimental medicine.

[55]  Stephen T. C. Wong,et al.  Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. , 2013, Cell metabolism.

[56]  Reiko Nishihara,et al.  Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. , 2013, Cancer research.

[57]  M. VanSaun Molecular Pathways Molecular Pathways : Adiponectin and Leptin Signaling in Cancer , 2013 .

[58]  J. Manson,et al.  A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. , 2013, Journal of the National Cancer Institute.

[59]  R. Flavell,et al.  JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation , 2013, Science.

[60]  A. Tessitore,et al.  The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages , 2012, BioMed research international.

[61]  R. Kittler,et al.  Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer , 2012, Proceedings of the National Academy of Sciences.

[62]  H. El‐Serag,et al.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[63]  P. Scherer,et al.  Adipocyte-derived endotrophin promotes malignant tumor progression. , 2012, The Journal of clinical investigation.

[64]  Lincoln D. Stein,et al.  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.

[65]  F. Carbone,et al.  Immunological functions of leptin and adiponectin. , 2012, Biochimie.

[66]  Mary T. Brinkoetter,et al.  Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice , 2012, Gut.

[67]  N. Jhala,et al.  Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. , 2012, Cancer cell.

[68]  D. Bar-Sagi,et al.  Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. , 2012, Cancer cell.

[69]  M. Lotze,et al.  AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway , 2012, Autophagy.

[70]  L. Fartoux,et al.  HCC and NASH: how strong is the clinical demonstration? , 2012, Clinics and research in hepatology and gastroenterology.

[71]  C. Mantzoros,et al.  The role of adiponectin in cancer: a review of current evidence. , 2012, Endocrine reviews.

[72]  C. Benoist,et al.  PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells , 2012, Nature.

[73]  A. Chumanevich,et al.  Adiponectin deficiency: role in chronic inflammation induced colon cancer. , 2012, Biochimica et biophysica acta.

[74]  Shanchun Guo,et al.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. , 2012, Biochimica et biophysica acta.

[75]  Douglas Hanahan,et al.  Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .

[76]  B. Spiegelman,et al.  Molecular mechanisms of cancer development in obesity , 2011, Nature Reviews Cancer.

[77]  J. Drew Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin , 2011, Proceedings of the Nutrition Society.

[78]  V. Tutino,et al.  Increased soluble leptin receptor levels are associated with advanced tumor stage in colorectal cancer patients. , 2011, Anticancer research.

[79]  C. la Vecchia,et al.  Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis. , 2011, Metabolism: clinical and experimental.

[80]  E. Riboli,et al.  Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort , 2011, Diabetologia.

[81]  G. Coukos,et al.  The parallel lives of angiogenesis and immunosuppression: cancer and other tales , 2011, Nature Reviews Immunology.

[82]  H. El-Mesallamy,et al.  The interplay of YKL-40 and leptin in type 2 diabetic obese patients. , 2011, Diabetes research and clinical practice.

[83]  Michael Karin,et al.  Inflammation meets cancer, with NF-κB as the matchmaker , 2011, Nature Immunology.

[84]  J. Arthur,et al.  Leptin up‐regulates pro‐inflammatory cytokines in discrete cells within mouse colon , 2011, Journal of cellular physiology.

[85]  D. Leroith,et al.  Minireview: IGF, Insulin, and Cancer. , 2011, Endocrinology.

[86]  J. Samet,et al.  Total cholesterol and cancer risk in a large prospective study in Korea. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  R. Locksley,et al.  Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis , 2011, Science.

[88]  Yuan Yuan Wang,et al.  Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. , 2011, Cancer research.

[89]  K. Takeda,et al.  Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis , 2011, Gut.

[90]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[91]  Vilmundur Gudnason,et al.  Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death , 2011 .

[92]  M. Karin,et al.  Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage , 2011, Annals of the rheumatic diseases.

[93]  M. Kolonin,et al.  Influence of BMI on Level of Circulating Progenitor Cells , 2011, Obesity.

[94]  M. Suárez-Fariñas,et al.  Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis. , 2011, The American journal of clinical nutrition.

[95]  M. Karin,et al.  Role of TLR2‐dependent inflammation in metastatic progression , 2011, Annals of the New York Academy of Sciences.

[96]  N. Zarghami,et al.  The Possible Impact of Obesity on Androgen, Progesterone and Estrogen Receptors (ERα and ERβ) Gene Expression in Breast Cancer Patients , 2011, Breast cancer : basic and clinical research.

[97]  R. Locksley,et al.  IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity , 2010, Proceedings of the National Academy of Sciences.

[98]  H. Tilg,et al.  Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis , 2010, Hepatology.

[99]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[100]  Yuichi Akasaki,et al.  Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity , 2010, Science.

[101]  J. Fenton,et al.  Adipokine regulation of colon cancer: Adiponectin attenuates interleukin‐6‐induced colon carcinoma cell proliferation via STAT‐3 , 2010, Molecular carcinogenesis.

[102]  M. Coory,et al.  Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis , 2010, Breast Cancer Research and Treatment.

[103]  M. Inoue,et al.  Insulin resistance and cancer: Epidemiological evidence , 2010, Cancer science.

[104]  F. Greenway,et al.  Obesity Increases the Production of Proinflammatory Mediators from Adipose Tissue T Cells and Compromises TCR Repertoire Diversity: Implications for Systemic Inflammation and Insulin Resistance , 2010, The Journal of Immunology.

[105]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[106]  Wei Zheng,et al.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.

[107]  R. Odze,et al.  Aga Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease Learning Objectives Are Patients with Ibd at Increased Risk for Developing Crc? Uc , 2022 .

[108]  Jun Hee Lee,et al.  Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.

[109]  D. Nomura,et al.  Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.

[110]  C. Picó,et al.  Gene Expression Patterns in Visceral and Subcutaneous Adipose Depots in Rats are Linked to Their Morphologic Features , 2009, Cellular Physiology and Biochemistry.

[111]  Isao Usui,et al.  Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice , 2009, Diabetes.

[112]  S. Lipkin,et al.  Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. , 2009, Cancer research.

[113]  T. Kadowaki,et al.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity , 2009, Nature Medicine.

[114]  Christophe Benoist,et al.  Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters , 2009, Nature Medicine.

[115]  H. Pitt,et al.  Obesity potentiates the growth and dissemination of pancreatic cancer. , 2009, Surgery.

[116]  C. Bouchard,et al.  Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. , 2009, The Lancet. Oncology.

[117]  F. Balkwill Tumour necrosis factor and cancer , 2009, Nature Reviews Cancer.

[118]  E. Calle,et al.  Cancer Incidence and Mortality After Gastric Bypass Surgery , 2009, Obesity.

[119]  A. Walch,et al.  Inflammation and mitochondrial fatty acid β-oxidation link obesity to early tumor promotion , 2009, Proceedings of the National Academy of Sciences.

[120]  M. Vasson,et al.  IL‐1 family in breast cancer: Potential interplay with leptin and other adipocytokines , 2009, FEBS letters.

[121]  B. Aggarwal,et al.  Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe , 2009, Clinical Cancer Research.

[122]  N. Zeps,et al.  Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  E. Giovannucci,et al.  Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer , 2008, Clinical Cancer Research.

[124]  M. Pollak,et al.  Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.

[125]  B. Aggarwal,et al.  Cancer is a Preventable Disease that Requires Major Lifestyle Changes , 2008, Pharmaceutical Research.

[126]  H. Reber,et al.  Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. , 2008, Surgery.

[127]  Vidya Subramanian,et al.  Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. , 2008, Cell metabolism.

[128]  M. Czech,et al.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.

[129]  M. Karin,et al.  The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. , 2008, Trends in molecular medicine.

[130]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[131]  J. Leips,et al.  Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. , 2007, Cancer research.

[132]  D. Tuveson,et al.  Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.

[133]  Charles F Burant,et al.  The rapidly expanding family of adipokines. , 2007, Cell metabolism.

[134]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[135]  Zheng Zhang,et al.  Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. , 2007, Gastroenterology.

[136]  P. Rothwell,et al.  Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies , 2007, The Lancet.

[137]  R. Rosenfeld Work , 2007, Sometime Kin.

[138]  H. Alexander,et al.  Journal of Translational Medicine Interleukin-1 and Cancer Progression: the Emerging Role of Interleukin-1 Receptor Antagonist as a Novel Therapeutic Agent in Cancer Treatment , 2022 .

[139]  A. Renehan,et al.  Obesity and cancer risk: the role of the insulin–IGF axis , 2006, Trends in Endocrinology & Metabolism.

[140]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[141]  M. Karin,et al.  Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[142]  J. Johansen Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. , 2006, Danish medical bulletin.

[143]  G. Kundu,et al.  Osteopontin: role in cell signaling and cancer progression. , 2006, Trends in cell biology.

[144]  D. Albanes,et al.  Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. , 2005, JAMA.

[145]  Michael Karin,et al.  IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.

[146]  C. Stove,et al.  Roles for neuregulins in human cancer , 2005, Clinical & Experimental Metastasis.

[147]  R. Stubbs,et al.  Loss of Insulin Resistance after Roux-en-Y Gastric Bypass Surgery: a Time Course Study , 2005, Obesity surgery.

[148]  A. Hevener,et al.  IKK-β links inflammation to obesity-induced insulin resistance , 2005, Nature Medicine.

[149]  J. Samet,et al.  Fasting serum glucose level and cancer risk in Korean men and women. , 2005, JAMA.

[150]  K. Clément,et al.  The FASEB Journal • Research Communication Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects , 2022 .

[151]  M. Singer,et al.  BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults , 2004, International Journal of Obesity.

[152]  E. Bleecker,et al.  Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. , 2004, The American journal of clinical nutrition.

[153]  B. Sipos,et al.  Tumor Stroma Interactions Induce Chemoresistance in Pancreatic Ductal Carcinoma Cells Involving Increased Secretion and Paracrine Effects of Nitric Oxide and Interleukin-1β , 2004, Cancer Research.

[154]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[155]  Jayadev Raju,et al.  Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. , 2003, Cancer research.

[156]  D. Mcfadden,et al.  Differential effects of leptin on cancer in vitro. , 2003, The Journal of surgical research.

[157]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[158]  R. Schwabe,et al.  c‐Jun‐N‐terminal kinase drives cyclin D1 expression and proliferation during liver regeneration , 2003, Hepatology.

[159]  R. Marfella,et al.  Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.

[160]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[161]  S. Deventer,et al.  Leptin is a growth factor for colonic epithelial cells. , 2001, Gastroenterology.

[162]  P. Schauer,et al.  Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity , 2000, Annals of surgery.

[163]  S. Kihara,et al.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.

[164]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[165]  B Rosner,et al.  Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. , 1999, American journal of epidemiology.

[166]  Gretchen A. Stevens,et al.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.

[167]  C. Mantzoros,et al.  Leptin in nonalcoholic fatty liver disease: a narrative review. , 2015, Metabolism: clinical and experimental.

[168]  R. Dalle Grave,et al.  Increased Risk of Colorectal Cancer After Obesity Surgery. , 2015, Annals of surgery.

[169]  L. Hebbard,et al.  Multifaceted roles of adiponectin in cancer. , 2014, Best practice & research. Clinical endocrinology & metabolism.

[170]  K. Cho,et al.  Imaging white adipose tissue with confocal microscopy. , 2014, Methods in enzymology.

[171]  Christopher J. Lyon,et al.  Inflammasomes and Obesity , 2013 .

[172]  G. Musso,et al.  Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. , 2013, Progress in lipid research.

[173]  Sagar Ghosh,et al.  An IL-6 link between obesity and cancer. , 2013, Frontiers in bioscience.

[174]  M. Karin,et al.  Hepatocyte IKK β / NF-κ B inhibits tumor promotion and progression by preventing oxidative stress driven STAT 3 activation , 2010 .

[175]  S. Yakar,et al.  Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis. , 2010, Cancer research.

[176]  M. Ruth Normalization of obesity-associated insulin resistance through immunotherapy , 2010 .

[177]  P. Siiteri Adipose tissue as a source of hormones. , 1987, The American journal of clinical nutrition.